Pulmonary hypertension Historical Perspective

Revision as of 14:59, 27 March 2018 by Anmol Pitliya (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Right heart catheterization

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension Historical Perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension Historical Perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension Historical Perspective

CDC on Pulmonary hypertension Historical Perspective

Pulmonary hypertension Historical Perspective in the news

Blogs on Pulmonary hypertension Historical Perspective

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In 1891, a German physician Ernst von Romberg described pulmonary vascular sclerosis in an autopsy. In 1951 David Dresdale coined the term primary pulmonary hypertension for the first time. In 1951, David Dresdale coined the term primary pulmonary hypertension for the first time. In 1981, pulmonary hypertension registry landmark multi-center U.S. study characterizing natural history and clinical features of primary pulmonary hypertension (PPH).

Historical Perspective

  • The historical perspective of the PH is as follows:[1][2]
    • In 1891, a German physician Ernst von Romberg described pulmonary vascular sclerosis in an autopsy.
    • In 1901, Abel Ayerza Key lecture integrating cyanosis and right heart failure, named the condition as cardiac negro - black heart.
    • In 1913, F. C. Arrillaga, assigned syphilitic arteriosclerosis as etiology of PH; changed the name of disease to Ayerza’s Disease.
    • In 1929, Werner Forssman demonstrated that it was possible to perform right sided catheterization in humans by performing catheterization on himself.
    • In 1951, David Dresdale coined the term primary pulmonary hypertension for the first time.
    • In 1956, Forssman, Cournand, and Richards were awarded the Nobel Prize for their contributions to the discovery of circulatory and cardiopulmonary systems.
    • In 1958, Paul Wood published pulmonary hypertension with an association with a vasoconstrictive factor.
    • During 1965–1970s, first pulmonary hypertension epidemic related to the approval of Aminorex.
    • In 1973, 1st WHO Meeting on pulmonary hypertension the landmark meeting about pulmonary hypertension, provided recommendations for future directions.
    • In 1981, pulmonary hypertension registry landmark multi-center U.S. study characterizing natural history and clinical features of primary pulmonary hypertension (PPH).
    • In 1998, 2nd World Symposium on pulmonary hypertension, formation of Evian Classification of pulmonary hypertension and the term pulmonary arterial hypertension (PAH) was coined.
    • In 2003, 3rd World Symposium on pulmonary hypertension, formation of Venice Classification; idiopathic PAH introduced to replace term PPH.
    • In 2008, 4th World Symposium on pulmonary hypertension, formation of Dana Point Classification; modification of genetic category, among others in Group 1.
    • In 2013, 5th World Symposium on pulmonary hypertension, formation of Nice Classification; further modifications of genetic category, among others in Group 1.
    • In 2014, International Right Heart Failure Foundation - comprehensive nomenclature of RHF (right heart failure) defining distinction between right heart failure vs right ventricular failure vs components of right heart system, and the definition of right heart failure.

References

  1. Smith DB (1989). "Continent diversions: an overview". Dimens Oncol Nurs. 3 (4): 18–23. PMID 2700428.
  2. KIRKENDALL WM, GIFFORD RW, HORWITZ D, WILSON WR, GOLDBERG LI, GROLLMAN A (August 1963). "General aspects of hypertension; past, present and future". Postgrad Med. 34: 150–6. PMID 14033007.




Linked-in.jpg